Assessment of Chemotherapy-Induced Nausea and Vomiting in Women With Breast Cancer: A Neuman Systems Model Framework
Authors:
- 1 January 2013
- journal article
- Published by Springer Publishing Company in Research and Theory for Nursing Practice
- Vol. 27 (4) , 296-304
Abstract
The importance of nursing theory and models for the development of the nursing profession is becoming increasingly evident in literature. This article demonstrates the use of the Betty Neuman Systems Model (NSM) to assess, as well as determine the predictors of chemotherapy-induced nausea and vomiting (CINV) in patients diagnosed with breast cancer receiving doxorubicin-based chemotherapy. The selection of the model for practice reflects the congruency between the level of severity of CINV and the patient-related risk factors. In addition, the NSM was used to determine the appropriate nursing interventions necessary to strengthen the flexible lines of defense and the lines of resistance in addition to maintaining system stability.Keywords
This publication has 25 references indexed in Scilit:
- Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trialSupportive Care in Cancer, 2013
- Prospective Validation of Risk Prediction Indexes for Acute and Delayed Chemotherapy-Induced Nausea and VomitingCurrent Oncology, 2012
- Antiemetic Control with Palonosetron in Patients with Gastrointestinal Cancer Receiving a Fluoropyrimidine-Based Regimen in Addition to Either Irinotecan or Oxaliplatin: A Retrospective StudyOncology, 2012
- Chemotherapy-Induced Nausea and Vomiting in Asian Women With Breast Cancer Receiving Anthracycline-Based Adjuvant ChemotherapyJournal of Supportive Oncology, 2012
- Antiemetics for Chemotherapy-Induced Nausea and Vomiting Occurring Despite Prophylactic Antiemetic TherapyJournal of Palliative Medicine, 2011
- Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a US populationSupportive Care in Cancer, 2010
- Chemotherapy-induced nausea and vomiting—incidence and impact on patient quality of life at community oncology settingsSupportive Care in Cancer, 2006
- Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatmentEuropean Journal of Cancer, 2005
- Dose-dense chemotherapy in breast cancer and lymphomaSeminars in Oncology, 2004
- Chemotherapy-Induced Nausea and VomitingClinical Journal of Oncology Nursing, 2002